Ireland rubber-stamps VHI chairman reappointment
This article was originally published in Clinica
Executive Summary
Bernard Collins has been re-appointed as chairman of Vhi Healthcare (VHI), Ireland's leading healthcare insurer-provider, for a further five years, with effect from today (September 24), the health ministry announced yesterday. Mr Collins is CEO of Lifemed Consulting and has board-level positions on other companies in Ireland and in the US. He served for 10 years as VP, international operations, at Boston Scientific until 2003.
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.
England’s NICE Says No To Santhera’s DMD Drug Agamree Due To ‘Unreliable Modeling’
Santhera Pharmaceuticals did not provide enough evidence to demonstrate that its Duchenne muscular dystrophy drug Agamree was a cost-effective use of resources, according to draft guidance from England’s health technology assessment body, NICE.